µ²ºc¦¡ |
|
Verapamil 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl)pentanenitrile
|
UpToDate |
UpToDate ³sµ²
|
ÃIJz§@¥Î |
|
¿ï¾Ü©Ê¶tÂ÷¤lªýÂ_¾¯¡Aª½±µ§@¥Î©ó¤ßŦ¡Aphenylalkylaminel¥Íª«¡C
|
¾AÀ³¯g |
|
°ª¦åÀ£¡C
|
¥Îªk¥Î¶q |
|
»P¹ª«¦PªA¡C¤@¯ë¾¯¶q¬°¨C¤é120-240mg¡A©ó¦¤WªA¥Î¡A¨Ì§ëÃÄ8¤p®É«áªº¤ÏÀ³½Õ¾ã¾¯¶q¡C ¥Ñ¿õ¾¯Âà´«¦¨½wÄÀ¾¯«¬®É¥i¨Ï¥Î¦Pµ¥¾¯¶q¡C
|
ÃİʤO¾Ç |
|
§l¦¬¡G ¶W¹L90¢HªºVerapamil¦Û¤p¸z§Ö³tªº³Q§l¦¬¡C¥Ñ©ó¼sªxªº¨xŦ¤â´ç¥NÁ¡A³æ¾¯¶qªº³t®ÄVerapamil쫬ÃÄ¥§¡¥þ¨¥i¥Î²v¬°22¢H¡A«ùÄòÃÄ®ÄVerapamil¥§¡¥þ¨¥i¥Î²v¬°33¢H¡C³sÄòµ¹ÃĤ§¥ÍÅé¥i¥Î²v¬ù¬°2¿°ª¡C Verapamil¦b§ë»P«ùÄòÃĮĩw¬°4¡ã5¤p®É«á¡C ¤À§G¡G Verapamilªº¦å¼ß³J¥Õµ²¦X²v¬ù¬°90¢H¡C ¥NÁÂ: ¥»«~³Q¼sªx¥NÁ¡C ±Æªn¡G ±Æ°£¥b°I´Á¬°3¡ã7¤p®É¡CVerapamil¤Î¨ä¥NÁª«¥Dn¸g¥ÑµÇŦ¸ô®|±Æ°£¡C
|
°Æ§@¥Î |
|
ÀYµh¡B¯t·w¡Bäú¤ß¡B«K¯¦©M¸¡µh¡C
|
¥æ¤¬§@¥Î |
|
§Ü¤ß«ß¤£¾ãÃÄ¡A £]- ªýÂ_¾¯¡G 1. »P £]-Blocking Agent ¨Ö¥Î¥i¯à·|¼W±j©Ð«Ç¶Ç¾ÉªýÂ_¡B½w¯ß¡B§C¦åÀ£¡B¤ßŦ°IºÜ¤è ±ªº§@¥Î¡C 2. Digitalis¡G ªø´Á¥Hverapamil hydrochloride ªvÀø·|¼W¥[¦å²MDigoxin Level 50% ¦Ü70%¡A³Ìªì²Ä ¤@¶gªvÀø¡A¨Ã³y¦¨¤ò¦a¶À¤¤¬r¡C 3. Antihypertension Drug¡G »P¤fªA°¦åÀ£¾¯ ( ¨Ò¦p¡G¦åºÞÃP¦¢¾¯¡B§Q§¿¾¯) ¨Ö¥Î¡A·|¼W±j°¦åÀ£¤§§@¥Î¡C 4. Disopyramide¡G ¦bªA¥Îverapamil HCl «e48 ¤p®É»PªA¥Î«á24 ¤p®É´Á¶¡¤£¥iªA¥Î¡C 5.°sºë¡G ·|¼W¥[°sºëªº¦å¤¤¿@«×¡C 6.¨Ï¥Îverapamil ªº¯f¤HYn¨Ö¥ÎHMG Co-A ÁÙì酶§í¨î¾¯ ( ¦p¡A simvastatin¡Batorvastatin ©Îlovastatin) À³¥Ñ³Ì§C¾¯¶q¶}©l¡A³vº¥©¹¤W½Õ¾ã¾¯¶q¡CY ¬O¤w¸g¨Ï¥ÎHMG Co-A ÁÙì酶§í¨î¾¯ ( ¦psimvastatin¡Batorvastatin ©Îlovastatin) ªº¯f¤Hn¦P®É¨Ö¥Îverapamil¡A»Ýn¦Ò¼{¥ý±Nstatin ªº¾¯¶q°§C¡A¦A¨Ì¾Ú¦å²M¤¤Áx©T¾Jªº¿@«×¨Ó½Õ
|
¸T§Ò |
|
(1) ¹ïverapamil¬¡©Êª«©Î¨ä¥L¥ô¦ó«D¬¡©Ê¦¨¤À¹L±Ó¡C (2) ¤ß¦]©Ê¥ð§J¡C (3) ²Ä¤G©Î²Ä¤T¯Å©Ð«ÇªýÂ_(¦³¤H¤u¤ß«ß½Õ¸`¾¹§´µ½¹B§@ªº¯f¤H°£¥~) (4) ¯fºAÄu¯gÔ¸s(¦³¤H¤u¤ß«ß½Õ¸`¾¹§´µ½¹B§@ªº¯f¤H°£¥~)¡C (5) ¤ß°IºÜ(¨Ò¦p:¤ßŦ®g¥X²v§C©ó 35%¡A©M/©ÎªÍ°Ê¯ß·¤À£20²@¦Ì¨E¬W¥H¤W) (verapamil ªvÀø¾ÉPªºÄ~µo©Ê¤ß«Ç¤WÀW¯ß°£¥~)¡C (6) ¤ß©Ð¼³°Ê»P¤ß©ÐÅÖºûŸ°Ê¨Ö©Ð«Ç°Æ³~®| (¨Ò¦p¡GWolff-Parkinson-Whitesyndrome©ÎLown-Ganong-Levine Syndromes)¡C³oÃþ¯f±wY¨Ï¥Îverapamil hydrochloride¡A·|³B©ó²£¥Í¤ß«ÇÀW¯ß (¥]¬A¤ß«ÇÅÖºûŸ°Ê) ªº·ÀI¡C (7) ÄY«¥ª¤ß«Ç¥\¯à¤£¨}¡C (8) §C¦åÀ£ (¦¬ÁYÀ£¤p©ó90mmHg)¡C (9) ¨Ö¥Î Ivabradine¡C
|
ª`·N¨Æ¶µ |
|
¤@¡B ¦³¤U¦C±¡ªp®É¡A¶·¤p¤ß¨Ï¥Î¡G 1. ²Ä¤@¯Å©Ð«ÇªýÂ_ (First degree AV block) 2. §C¦åÀ£ ƒÜ 3. ¤ß·i®}½w (Bradycardia) 4. ««×¨x¥\¯à¤£¥þ¡G ¥Ñ©óverapamil hydrochloride¦b¨xŦ¦³«Ü°ªªº¥NÁ§@¥Î¡A¦]¦¹¨x¥\¯à¤£¥þªº¯f¤Hn¤p¤ß§ë»P¡C««×ªº¨x¥\¯à¤£¥þ±N·|©µªø¥»«~ªº±Æ°£¥b°I´Á¦Ü14-16¤p®É¡C©Ò¥H§ë»P¨x¥\¯à¤£¥þ±wªÌªº¾¯¶q ¥u¯à¬°¤@¯ë¥¿±`¾¯¶qªº30%¡C 5. µÇ¥\¯à¤£¥þ¡G ¤j¬ù¦³70%§ë»PÃĪ«ªº¥NÁ²£ª«¥Ñ§¿²G±Æ°£¡A¦]¦¹n¤p¤ßªA¥Î¡C 6. ±w¦³¼vÅT¯«¸g¦Ù¦×¶Ç¾É¤§¯e¯f («¯g¦ÙµL¤O¡BLambert-Eaton ¯gÔ¸s¡BÄY«Duchenne«¬¦ÙµäÁY) ¤G¡B ±w¦³½ÆÂø¤§¤ß¦Ù±ð¶ë¤Î¤ßŦ©Ê¥ð§JªÌ¶··V«µ¹ÃĤÎÄY¥[ºÊ·þ¡C ¤T¡B ¦³¸£¦åºÞ¯fÅÜ¡A¤ßŦªýê¤Î°ª¦åÀ£±wªÌ¨Ï¥Îverapamil©Î´£°ª¾¯¶q®É¡A¶·¯S§O¤p¤ß¡C ¥|¡B °¸¦³«K¯µ¡B¹½¹¡Bäú¤ßµ¥G¸z¯gª¬¡A¯t·w¡B·n®Ì·Pµ¥§C¦åÀ£¯gª¬¡C ¤¡B Verapamil¨Ã¤£¯àªý¤î«æ©Ê¯U¤ß¯gµo§@¡C
|
¶¼¹´£¥Ü |
|
¨Ï¥Îverapamil ®É¨ÖªA¸²µå¬c©Î¸²µå¬c¥Ä®É¡AÀ³ª`·N¥i¯à²£¥Íªº¬Û¤¬§@¥Î¡C
|
ĵ»y |
|
¥i¯à·|¼vÅT¤ÏÀ³³t«×¦Ó´î®z¾r¾p©Î¾Þ§@¾÷¾¹©Î¦b¦MÀI ¤u§@Àô¹Ò¤Uªº¯à¤O¡C³o¤è±ªº¼vÅT¤×¨ä¬O¦b¶}©lªvÀø®É¡B·í¾¯¶q¤É°ª®É¡B©Îè±q ¥LÃÄ´«ªAverapamil®É¤Î»P°sºë¤@°_ªA¥Î®É¡C
|
¹L¶q³B²z |
|
¦pªGèªA¥Î¤£¤[¡A¥i¶Ê¦R¡B¬~G©M¾ÉÂm¡CÁöµMª`®g§ë»P¶t¡B £]µÇ¤W¸¢¨ë¿E¯À©MG¸zÄé¬~³Q¨Ï¥Î©ó¹L¶q¤W¡A¦ý¥»«~¹L¶q¤§ªvÀøÀ³¥H¤ä«ù©ÊÀøªk¬°¥D¡C
|
ÃÄ«~«O¦s¤è¦¡ |
|
25¢J¥H¤UÁ×¥úÀx¦s¡C
|